Does INSULIN GLARGINE Cause Device physical property issue? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Device physical property issue have been filed in association with INSULIN GLARGINE (Lantus Solostar). This represents 0.0% of all adverse event reports for INSULIN GLARGINE.
5
Reports of Device physical property issue with INSULIN GLARGINE
0.0%
of all INSULIN GLARGINE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Device physical property issue From INSULIN GLARGINE?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Device physical property issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN GLARGINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN GLARGINE Cause?
Blood glucose increased (19,234)
Inappropriate schedule of product administration (8,982)
Product storage error (7,743)
Off label use (6,842)
Visual impairment (5,793)
Blood glucose decreased (4,552)
Drug ineffective (4,351)
Hypoglycaemia (4,212)
Injection site pain (3,574)
Device issue (3,175)
What Other Drugs Cause Device physical property issue?
SOMATROPIN (2,449)
PEGFILGRASTIM (1,376)
LEVONORGESTREL (506)
CARBIDOPA\LEVODOPA (219)
TREPROSTINIL (218)
CHLORHEXIDINE\ISOPROPYL ALCOHOL (107)
ADALIMUMAB (95)
ESTRADIOL (89)
BACLOFEN (77)
ALBUTEROL (55)
Which INSULIN GLARGINE Alternatives Have Lower Device physical property issue Risk?
INSULIN GLARGINE vs INSULIN GLARGINE-YFGN
INSULIN GLARGINE vs INSULIN GLARGINE\LIXISENATIDE
INSULIN GLARGINE vs INSULIN GLULISINE
INSULIN GLARGINE vs INSULIN HUMAN
INSULIN GLARGINE vs INSULIN LISPRO